Norges Bank’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-208,800
Closed -$5.31M 2122
2023
Q1
$5.31M Buy
208,800
+74,600
+56% +$1.9M ﹤0.01% 1736
2022
Q4
$3.92M Buy
+134,200
New +$3.92M ﹤0.01% 1837